NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

My biggest issue at this point is the delay that the SAPs have contributed to the trial. This SAP process has now been dragging on for over a year. Why couldn’t this work have been going on in parallel to looking at blinded data in 2018?? If the company drafts the SAP and gets regulatory approval of the document in 2018 then, once the database is ready, they could have applied it and shaved 6 months off this process. Under those circumstances, they probably would have had topline data for us at ASCO.

Very disappointing that they dragged the data out, using SAP and regulatory excuses. On the other hand, our trial will have more information about long term survival than ever in GBM.

We’re all beyond ready for news...